Skip to main content
Clinical Trials/NCT00467675
NCT00467675
Completed
Not Applicable

Observational Study of Interstitial Glucose Monitoring With the FreeStyle Navigator CGM System to Develop Novel Methods for Displaying, Reporting and Analyzing CGM Data for Clinical Decision-Making: Phase 2-Establishing Ambulatory Glucose Profiles for Individuals Without Diabetes

HealthPartners Institute1 site in 1 country35 target enrollmentApril 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
NonDiabetes
Sponsor
HealthPartners Institute
Enrollment
35
Locations
1
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

In a previous study we used the FreeStyle Navigator Continuous Glucose Monitoring (CGM) System to obtain 30 days of glucose measurements from 30 people with diabetes treated with insulin. The purpose of this study is to characterize glycemia (glucose) control in 30 people without diabetes and to compare these data to the 30 people with diabetes from a previous study. Through this approach it may be possible to develop a means of establishing a model of normal glucose patterns and a basis of comparison with glucose patterns in people with diabetes.

Registry
clinicaltrials.gov
Start Date
April 2006
End Date
January 2007
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • Within normal range for two hour OGTT glucose level (\<140 mg/dl)
  • Within normal range for fasting glucose level (\<100 mg/dl)
  • Within normal range for total insulin level as measured by radioimmunoassay
  • BMI \<30kg/m2
  • Age 21-75 years of age, inclusive (15 subjects in the 21-49 years of age group, 15 subjects in the 50-75 years of age group)
  • Willing to give informed consent
  • Capable of following the protocol and instructions of study staff
  • Available for scheduled visits
  • Access to telephone communications

Exclusion Criteria

  • Under 21 years of age or over 75 years of age
  • Abnormal OGTT
  • Previous history of diabetes
  • Outside of normal insulin range
  • BMI \> 30kg/m2
  • Unable to follow protocol
  • Unable to read and write in English
  • Skin abnormalities at insertion sites
  • Allergy to adhesives
  • Any concomitant medical condition that would likely affect the evaluation of device performance

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials